LIU Update: Visit here for more information.

Faculty & Research Interests


Robert B. Young, Ph.D.
Research Assistant Professor, Pharmaceutical Sciences
(718) 488-1101


Ph.D., Colorado State University

Short Biography

Dr. Robert B. Young has joined the Arnold and Marie Schwartz College of Pharmacy and Health Sciences, LIU Brooklyn as a research assistant professor in metabolomics. He will work in the Division of Systems Pharmacology and Pharmacogenomics at The Samuel J. and Joan B. Williamson Institute. 

Dr. Young holds degrees from the University of Texas, Austin and from Columbia University. He graduated from Colorado State University in 2014 with a Ph.D. in environmental chemistry, and has considerable experience using targeted and nontargeted mass spectrometry analyses to detect and identify environmental pollutants and their transformation products in complex samples ranging from Arctic seal blubber to hydrocarbon contaminated soils and groundwater. Dr. Young’s analytical chemistry experience includes liquid and gas chromatography, tandem mass spectrometry, and high resolution mass spectrometry (time-of-flight, Orbitrap, and ion cyclotron resonance). He also has substantial programming experience, and has developed custom scripts to screen nontargeted mass spectrometry data for known environmental contaminants and identify compositional differences in complex environmental samples with more than 20,000 unique detected features.

Research Synopsis

In the systems pharmacology and pharmacogenomics lab, Dr. Young will be responsible for the day-to-day operation of the lab’s Waters Xevo G2-XS liquid chromatography quadrupole time-of flight mass spectrometer, Waters Xevo TQ-S micro liquid chromatography triple quadrupole mass spectrometer, and Agilent 5977B gas chromatography mass spectrometry systems. Dr. Young will perform targeted and nontargeted metabolomics and lipidomics analyses on biological fluids and tissue samples to support method development in precision medicine and investigate the mechanisms and treatment of progressive liver and other diseases. His current projects include collaborations with researchers in the Netherlands, Czech Republic and Harvard University to examine the mechanisms of encephalopathy in certain individuals treated with an anti-cancer drug, the occurrence and progression of multiple sclerosis in mouse models and the mechanisms of hepatic fibrogenesis in small animal models.

Recent Publications


LIU Pharmacy
John M. Pezzuto, Ph.D., D.Sc.